Global Coronary Drug-Coated Balloon Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Page: 71

Published Date: 09 Sep 2022

Category: Medical Devices & Consumables

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Product Tags

Description

The DEB may become a viable alternative treatment option for the inhibition of coronary restenosis and subsequent revascularisation, as it allows local release of a high-concentration antirestenotic drug, paclitaxel, into the coronary vessel without using a metal scaffold or durable polymers.

According to our (Global Info Research) latest study, the global Coronary Drug-Coated Balloon market size was valued at USD million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

This report is a detailed and comprehensive analysis for global Coronary Drug-Coated Balloon market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2022, are provided.

Key Features:
Global Coronary Drug-Coated Balloon market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2017-2028
Global Coronary Drug-Coated Balloon market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2017-2028
Global Coronary Drug-Coated Balloon market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2017-2028
Global Coronary Drug-Coated Balloon market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2017-2022
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Coronary Drug-Coated Balloon
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Coronary Drug-Coated Balloon market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include B. Braun, Yinyi, Eurocor and Biotronic, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market Segmentation
Coronary Drug-Coated Balloon market is split by Type and by Application. For the period 2017-2028, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Paclitaxel Coated
    Other Coated

Market segment by Application
    Hospitals
    ASCs
    Catheterization Laboratory

Major players covered
    B. Braun
    Yinyi
    Eurocor
    Biotronic

Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Coronary Drug-Coated Balloon product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Coronary Drug-Coated Balloon, with price, sales, revenue and global market share of Coronary Drug-Coated Balloon from 2017 to 2022.
Chapter 3, the Coronary Drug-Coated Balloon competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Coronary Drug-Coated Balloon breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Coronary Drug-Coated Balloon market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Coronary Drug-Coated Balloon.
Chapter 14 and 15, to describe Coronary Drug-Coated Balloon sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Coronary Drug-Coated Balloon Introduction
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Coronary Drug-Coated Balloon Consumption Value by Type: 2017 Versus 2021 Versus 2028
        1.3.2 Paclitaxel Coated
        1.3.3 Other Coated
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Coronary Drug-Coated Balloon Consumption Value by Application: 2017 Versus 2021 Versus 2028
        1.4.2 Hospitals
        1.4.3 ASCs
        1.4.4 Catheterization Laboratory
    1.5 Global Coronary Drug-Coated Balloon Market Size & Forecast
        1.5.1 Global Coronary Drug-Coated Balloon Consumption Value (2017 & 2021 & 2028)
        1.5.2 Global Coronary Drug-Coated Balloon Sales Quantity (2017-2028)
        1.5.3 Global Coronary Drug-Coated Balloon Average Price (2017-2028)

2 Manufacturers Profiles
    2.1 B. Braun
        2.1.1 B. Braun Details
        2.1.2 B. Braun Major Business
        2.1.3 B. Braun Coronary Drug-Coated Balloon Product and Services
        2.1.4 B. Braun Coronary Drug-Coated Balloon Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
        2.1.5 B. Braun Recent Developments/Updates
    2.2 Yinyi
        2.2.1 Yinyi Details
        2.2.2 Yinyi Major Business
        2.2.3 Yinyi Coronary Drug-Coated Balloon Product and Services
        2.2.4 Yinyi Coronary Drug-Coated Balloon Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
        2.2.5 Yinyi Recent Developments/Updates
    2.3 Eurocor
        2.3.1 Eurocor Details
        2.3.2 Eurocor Major Business
        2.3.3 Eurocor Coronary Drug-Coated Balloon Product and Services
        2.3.4 Eurocor Coronary Drug-Coated Balloon Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
        2.3.5 Eurocor Recent Developments/Updates
    2.4 Biotronic
        2.4.1 Biotronic Details
        2.4.2 Biotronic Major Business
        2.4.3 Biotronic Coronary Drug-Coated Balloon Product and Services
        2.4.4 Biotronic Coronary Drug-Coated Balloon Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
        2.4.5 Biotronic Recent Developments/Updates

3 Competitive Environment: Coronary Drug-Coated Balloon by Manufacturer
    3.1 Global Coronary Drug-Coated Balloon Sales Quantity by Manufacturer (2017-2022)
    3.2 Global Coronary Drug-Coated Balloon Revenue by Manufacturer (2017-2022)
    3.3 Global Coronary Drug-Coated Balloon Average Price by Manufacturer (2017-2022)
    3.4 Market Share Analysis (2021)
        3.4.1 Producer Shipments of Coronary Drug-Coated Balloon by Manufacturer Revenue ($MM) and Market Share (%): 2021
        3.4.2 Top 3 Coronary Drug-Coated Balloon Manufacturer Market Share in 2021
        3.4.2 Top 6 Coronary Drug-Coated Balloon Manufacturer Market Share in 2021
    3.5 Coronary Drug-Coated Balloon Market: Overall Company Footprint Analysis
        3.5.1 Coronary Drug-Coated Balloon Market: Region Footprint
        3.5.2 Coronary Drug-Coated Balloon Market: Company Product Type Footprint
        3.5.3 Coronary Drug-Coated Balloon Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Coronary Drug-Coated Balloon Market Size by Region
        4.1.1 Global Coronary Drug-Coated Balloon Sales Quantity by Region (2017-2028)
        4.1.2 Global Coronary Drug-Coated Balloon Consumption Value by Region (2017-2028)
        4.1.3 Global Coronary Drug-Coated Balloon Average Price by Region (2017-2028)
    4.2 North America Coronary Drug-Coated Balloon Consumption Value (2017-2028)
    4.3 Europe Coronary Drug-Coated Balloon Consumption Value (2017-2028)
    4.4 Asia-Pacific Coronary Drug-Coated Balloon Consumption Value (2017-2028)
    4.5 South America Coronary Drug-Coated Balloon Consumption Value (2017-2028)
    4.6 Middle East and Africa Coronary Drug-Coated Balloon Consumption Value (2017-2028)

5 Market Segment by Type
    5.1 Global Coronary Drug-Coated Balloon Sales Quantity by Type (2017-2028)
    5.2 Global Coronary Drug-Coated Balloon Consumption Value by Type (2017-2028)
    5.3 Global Coronary Drug-Coated Balloon Average Price by Type (2017-2028)

6 Market Segment by Application
    6.1 Global Coronary Drug-Coated Balloon Sales Quantity by Application (2017-2028)
    6.2 Global Coronary Drug-Coated Balloon Consumption Value by Application (2017-2028)
    6.3 Global Coronary Drug-Coated Balloon Average Price by Application (2017-2028)

7 North America
    7.1 North America Coronary Drug-Coated Balloon Sales Quantity by Type (2017-2028)
    7.2 North America Coronary Drug-Coated Balloon Sales Quantity by Application (2017-2028)
    7.3 North America Coronary Drug-Coated Balloon Market Size by Country
        7.3.1 North America Coronary Drug-Coated Balloon Sales Quantity by Country (2017-2028)
        7.3.2 North America Coronary Drug-Coated Balloon Consumption Value by Country (2017-2028)
        7.3.3 United States Market Size and Forecast (2017-2028)
        7.3.4 Canada Market Size and Forecast (2017-2028)
        7.3.5 Mexico Market Size and Forecast (2017-2028)

8 Europe
    8.1 Europe Coronary Drug-Coated Balloon Sales Quantity by Type (2017-2028)
    8.2 Europe Coronary Drug-Coated Balloon Sales Quantity by Application (2017-2028)
    8.3 Europe Coronary Drug-Coated Balloon Market Size by Country
        8.3.1 Europe Coronary Drug-Coated Balloon Sales Quantity by Country (2017-2028)
        8.3.2 Europe Coronary Drug-Coated Balloon Consumption Value by Country (2017-2028)
        8.3.3 Germany Market Size and Forecast (2017-2028)
        8.3.4 France Market Size and Forecast (2017-2028)
        8.3.5 United Kingdom Market Size and Forecast (2017-2028)
        8.3.6 Russia Market Size and Forecast (2017-2028)
        8.3.7 Italy Market Size and Forecast (2017-2028)

9 Asia-Pacific
    9.1 Asia-Pacific Coronary Drug-Coated Balloon Sales Quantity by Type (2017-2028)
    9.2 Asia-Pacific Coronary Drug-Coated Balloon Sales Quantity by Application (2017-2028)
    9.3 Asia-Pacific Coronary Drug-Coated Balloon Market Size by Region
        9.3.1 Asia-Pacific Coronary Drug-Coated Balloon Sales Quantity by Region (2017-2028)
        9.3.2 Asia-Pacific Coronary Drug-Coated Balloon Consumption Value by Region (2017-2028)
        9.3.3 China Market Size and Forecast (2017-2028)
        9.3.4 Japan Market Size and Forecast (2017-2028)
        9.3.5 Korea Market Size and Forecast (2017-2028)
        9.3.6 India Market Size and Forecast (2017-2028)
        9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
        9.3.8 Australia Market Size and Forecast (2017-2028)

10 South America
    10.1 South America Coronary Drug-Coated Balloon Sales Quantity by Type (2017-2028)
    10.2 South America Coronary Drug-Coated Balloon Sales Quantity by Application (2017-2028)
    10.3 South America Coronary Drug-Coated Balloon Market Size by Country
        10.3.1 South America Coronary Drug-Coated Balloon Sales Quantity by Country (2017-2028)
        10.3.2 South America Coronary Drug-Coated Balloon Consumption Value by Country (2017-2028)
        10.3.3 Brazil Market Size and Forecast (2017-2028)
        10.3.4 Argentina Market Size and Forecast (2017-2028)

11 Middle East & Africa
    11.1 Middle East & Africa Coronary Drug-Coated Balloon Sales Quantity by Type (2017-2028)
    11.2 Middle East & Africa Coronary Drug-Coated Balloon Sales Quantity by Application (2017-2028)
    11.3 Middle East & Africa Coronary Drug-Coated Balloon Market Size by Country
        11.3.1 Middle East & Africa Coronary Drug-Coated Balloon Sales Quantity by Country (2017-2028)
        11.3.2 Middle East & Africa Coronary Drug-Coated Balloon Consumption Value by Country (2017-2028)
        11.3.3 Turkey Market Size and Forecast (2017-2028)
        11.3.4 Egypt Market Size and Forecast (2017-2028)
        11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
        11.3.6 South Africa Market Size and Forecast (2017-2028)

12 Market Dynamics
    12.1 Coronary Drug-Coated Balloon Market Drivers
    12.2 Coronary Drug-Coated Balloon Market Restraints
    12.3 Coronary Drug-Coated Balloon Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry
    12.5 Influence of COVID-19 and Russia-Ukraine War
        12.5.1 Influence of COVID-19
        12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain
    13.1 Raw Material of Coronary Drug-Coated Balloon and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Coronary Drug-Coated Balloon
    13.3 Coronary Drug-Coated Balloon Production Process
    13.4 Coronary Drug-Coated Balloon Industrial Chain

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Coronary Drug-Coated Balloon Typical Distributors
    14.3 Coronary Drug-Coated Balloon Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Coronary Drug-Coated Balloon Consumption Value by Type, (USD Million), 2017 & 2021 & 2028
    Table 2. Global Coronary Drug-Coated Balloon Consumption Value by Application, (USD Million), 2017 & 2021 & 2028
    Table 3. B. Braun Basic Information, Manufacturing Base and Competitors
    Table 4. B. Braun Major Business
    Table 5. B. Braun Coronary Drug-Coated Balloon Product and Services
    Table 6. B. Braun Coronary Drug-Coated Balloon Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
    Table 7. B. Braun Recent Developments/Updates
    Table 8. Yinyi Basic Information, Manufacturing Base and Competitors
    Table 9. Yinyi Major Business
    Table 10. Yinyi Coronary Drug-Coated Balloon Product and Services
    Table 11. Yinyi Coronary Drug-Coated Balloon Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
    Table 12. Yinyi Recent Developments/Updates
    Table 13. Eurocor Basic Information, Manufacturing Base and Competitors
    Table 14. Eurocor Major Business
    Table 15. Eurocor Coronary Drug-Coated Balloon Product and Services
    Table 16. Eurocor Coronary Drug-Coated Balloon Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
    Table 17. Eurocor Recent Developments/Updates
    Table 18. Biotronic Basic Information, Manufacturing Base and Competitors
    Table 19. Biotronic Major Business
    Table 20. Biotronic Coronary Drug-Coated Balloon Product and Services
    Table 21. Biotronic Coronary Drug-Coated Balloon Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
    Table 22. Biotronic Recent Developments/Updates
    Table 23. Global Coronary Drug-Coated Balloon Sales Quantity by Manufacturer (2017-2022) & (Units)
    Table 24. Global Coronary Drug-Coated Balloon Revenue by Manufacturer (2017-2022) & (USD Million)
    Table 25. Global Coronary Drug-Coated Balloon Average Price by Manufacturer (2017-2022) & (US$/Unit)
    Table 26. Market Position of Manufacturers in Coronary Drug-Coated Balloon, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2021
    Table 27. Head Office and Coronary Drug-Coated Balloon Production Site of Key Manufacturer
    Table 28. Coronary Drug-Coated Balloon Market: Company Product Type Footprint
    Table 29. Coronary Drug-Coated Balloon Market: Company Product Application Footprint
    Table 30. Coronary Drug-Coated Balloon New Market Entrants and Barriers to Market Entry
    Table 31. Coronary Drug-Coated Balloon Mergers, Acquisition, Agreements, and Collaborations
    Table 32. Global Coronary Drug-Coated Balloon Sales Quantity by Region (2017-2022) & (Units)
    Table 33. Global Coronary Drug-Coated Balloon Sales Quantity by Region (2023-2028) & (Units)
    Table 34. Global Coronary Drug-Coated Balloon Consumption Value by Region (2017-2022) & (USD Million)
    Table 35. Global Coronary Drug-Coated Balloon Consumption Value by Region (2023-2028) & (USD Million)
    Table 36. Global Coronary Drug-Coated Balloon Average Price by Region (2017-2022) & (US$/Unit)
    Table 37. Global Coronary Drug-Coated Balloon Average Price by Region (2023-2028) & (US$/Unit)
    Table 38. Global Coronary Drug-Coated Balloon Sales Quantity by Type (2017-2022) & (Units)
    Table 39. Global Coronary Drug-Coated Balloon Sales Quantity by Type (2023-2028) & (Units)
    Table 40. Global Coronary Drug-Coated Balloon Consumption Value by Type (2017-2022) & (USD Million)
    Table 41. Global Coronary Drug-Coated Balloon Consumption Value by Type (2023-2028) & (USD Million)
    Table 42. Global Coronary Drug-Coated Balloon Average Price by Type (2017-2022) & (US$/Unit)
    Table 43. Global Coronary Drug-Coated Balloon Average Price by Type (2023-2028) & (US$/Unit)
    Table 44. Global Coronary Drug-Coated Balloon Sales Quantity by Application (2017-2022) & (Units)
    Table 45. Global Coronary Drug-Coated Balloon Sales Quantity by Application (2023-2028) & (Units)
    Table 46. Global Coronary Drug-Coated Balloon Consumption Value by Application (2017-2022) & (USD Million)
    Table 47. Global Coronary Drug-Coated Balloon Consumption Value by Application (2023-2028) & (USD Million)
    Table 48. Global Coronary Drug-Coated Balloon Average Price by Application (2017-2022) & (US$/Unit)
    Table 49. Global Coronary Drug-Coated Balloon Average Price by Application (2023-2028) & (US$/Unit)
    Table 50. North America Coronary Drug-Coated Balloon Sales Quantity by Type (2017-2022) & (Units)
    Table 51. North America Coronary Drug-Coated Balloon Sales Quantity by Type (2023-2028) & (Units)
    Table 52. North America Coronary Drug-Coated Balloon Sales Quantity by Application (2017-2022) & (Units)
    Table 53. North America Coronary Drug-Coated Balloon Sales Quantity by Application (2023-2028) & (Units)
    Table 54. North America Coronary Drug-Coated Balloon Sales Quantity by Country (2017-2022) & (Units)
    Table 55. North America Coronary Drug-Coated Balloon Sales Quantity by Country (2023-2028) & (Units)
    Table 56. North America Coronary Drug-Coated Balloon Consumption Value by Country (2017-2022) & (USD Million)
    Table 57. North America Coronary Drug-Coated Balloon Consumption Value by Country (2023-2028) & (USD Million)
    Table 58. Europe Coronary Drug-Coated Balloon Sales Quantity by Type (2017-2022) & (Units)
    Table 59. Europe Coronary Drug-Coated Balloon Sales Quantity by Type (2023-2028) & (Units)
    Table 60. Europe Coronary Drug-Coated Balloon Sales Quantity by Application (2017-2022) & (Units)
    Table 61. Europe Coronary Drug-Coated Balloon Sales Quantity by Application (2023-2028) & (Units)
    Table 62. Europe Coronary Drug-Coated Balloon Sales Quantity by Country (2017-2022) & (Units)
    Table 63. Europe Coronary Drug-Coated Balloon Sales Quantity by Country (2023-2028) & (Units)
    Table 64. Europe Coronary Drug-Coated Balloon Consumption Value by Country (2017-2022) & (USD Million)
    Table 65. Europe Coronary Drug-Coated Balloon Consumption Value by Country (2023-2028) & (USD Million)
    Table 66. Asia-Pacific Coronary Drug-Coated Balloon Sales Quantity by Type (2017-2022) & (Units)
    Table 67. Asia-Pacific Coronary Drug-Coated Balloon Sales Quantity by Type (2023-2028) & (Units)
    Table 68. Asia-Pacific Coronary Drug-Coated Balloon Sales Quantity by Application (2017-2022) & (Units)
    Table 69. Asia-Pacific Coronary Drug-Coated Balloon Sales Quantity by Application (2023-2028) & (Units)
    Table 70. Asia-Pacific Coronary Drug-Coated Balloon Sales Quantity by Region (2017-2022) & (Units)
    Table 71. Asia-Pacific Coronary Drug-Coated Balloon Sales Quantity by Region (2023-2028) & (Units)
    Table 72. Asia-Pacific Coronary Drug-Coated Balloon Consumption Value by Region (2017-2022) & (USD Million)
    Table 73. Asia-Pacific Coronary Drug-Coated Balloon Consumption Value by Region (2023-2028) & (USD Million)
    Table 74. South America Coronary Drug-Coated Balloon Sales Quantity by Type (2017-2022) & (Units)
    Table 75. South America Coronary Drug-Coated Balloon Sales Quantity by Type (2023-2028) & (Units)
    Table 76. South America Coronary Drug-Coated Balloon Sales Quantity by Application (2017-2022) & (Units)
    Table 77. South America Coronary Drug-Coated Balloon Sales Quantity by Application (2023-2028) & (Units)
    Table 78. South America Coronary Drug-Coated Balloon Sales Quantity by Country (2017-2022) & (Units)
    Table 79. South America Coronary Drug-Coated Balloon Sales Quantity by Country (2023-2028) & (Units)
    Table 80. South America Coronary Drug-Coated Balloon Consumption Value by Country (2017-2022) & (USD Million)
    Table 81. South America Coronary Drug-Coated Balloon Consumption Value by Country (2023-2028) & (USD Million)
    Table 82. Middle East & Africa Coronary Drug-Coated Balloon Sales Quantity by Type (2017-2022) & (Units)
    Table 83. Middle East & Africa Coronary Drug-Coated Balloon Sales Quantity by Type (2023-2028) & (Units)
    Table 84. Middle East & Africa Coronary Drug-Coated Balloon Sales Quantity by Application (2017-2022) & (Units)
    Table 85. Middle East & Africa Coronary Drug-Coated Balloon Sales Quantity by Application (2023-2028) & (Units)
    Table 86. Middle East & Africa Coronary Drug-Coated Balloon Sales Quantity by Region (2017-2022) & (Units)
    Table 87. Middle East & Africa Coronary Drug-Coated Balloon Sales Quantity by Region (2023-2028) & (Units)
    Table 88. Middle East & Africa Coronary Drug-Coated Balloon Consumption Value by Region (2017-2022) & (USD Million)
    Table 89. Middle East & Africa Coronary Drug-Coated Balloon Consumption Value by Region (2023-2028) & (USD Million)
    Table 90. Coronary Drug-Coated Balloon Raw Material
    Table 91. Key Manufacturers of Coronary Drug-Coated Balloon Raw Materials
    Table 92. Coronary Drug-Coated Balloon Typical Distributors
    Table 93. Coronary Drug-Coated Balloon Typical Customers
List of Figures
    Figure 1. Coronary Drug-Coated Balloon Picture
    Figure 2. Global Coronary Drug-Coated Balloon Consumption Value by Type, (USD Million), 2017 & 2021 & 2028
    Figure 3. Global Coronary Drug-Coated Balloon Consumption Value Market Share by Type in 2021
    Figure 4. Paclitaxel Coated Examples
    Figure 5. Other Coated Examples
    Figure 6. Global Coronary Drug-Coated Balloon Consumption Value by Application, (USD Million), 2017 & 2021 & 2028
    Figure 7. Global Coronary Drug-Coated Balloon Consumption Value Market Share by Application in 2021
    Figure 8. Hospitals Examples
    Figure 9. ASCs Examples
    Figure 10. Catheterization Laboratory Examples
    Figure 11. Global Coronary Drug-Coated Balloon Consumption Value, (USD Million): 2017 & 2021 & 2028
    Figure 12. Global Coronary Drug-Coated Balloon Consumption Value and Forecast (2017-2028) & (USD Million)
    Figure 13. Global Coronary Drug-Coated Balloon Sales Quantity (2017-2028) & (Units)
    Figure 14. Global Coronary Drug-Coated Balloon Average Price (2017-2028) & (US$/Unit)
    Figure 15. Global Coronary Drug-Coated Balloon Sales Quantity Market Share by Manufacturer in 2021
    Figure 16. Global Coronary Drug-Coated Balloon Consumption Value Market Share by Manufacturer in 2021
    Figure 17. Producer Shipments of Coronary Drug-Coated Balloon by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
    Figure 18. Top 3 Coronary Drug-Coated Balloon Manufacturer (Consumption Value) Market Share in 2021
    Figure 19. Top 6 Coronary Drug-Coated Balloon Manufacturer (Consumption Value) Market Share in 2021
    Figure 20. Global Coronary Drug-Coated Balloon Sales Quantity Market Share by Region (2017-2028)
    Figure 21. Global Coronary Drug-Coated Balloon Consumption Value Market Share by Region (2017-2028)
    Figure 22. North America Coronary Drug-Coated Balloon Consumption Value (2017-2028) & (USD Million)
    Figure 23. Europe Coronary Drug-Coated Balloon Consumption Value (2017-2028) & (USD Million)
    Figure 24. Asia-Pacific Coronary Drug-Coated Balloon Consumption Value (2017-2028) & (USD Million)
    Figure 25. South America Coronary Drug-Coated Balloon Consumption Value (2017-2028) & (USD Million)
    Figure 26. Middle East & Africa Coronary Drug-Coated Balloon Consumption Value (2017-2028) & (USD Million)
    Figure 27. Global Coronary Drug-Coated Balloon Sales Quantity Market Share by Type (2017-2028)
    Figure 28. Global Coronary Drug-Coated Balloon Consumption Value Market Share by Type (2017-2028)
    Figure 29. Global Coronary Drug-Coated Balloon Average Price by Type (2017-2028) & (US$/Unit)
    Figure 30. Global Coronary Drug-Coated Balloon Sales Quantity Market Share by Application (2017-2028)
    Figure 31. Global Coronary Drug-Coated Balloon Consumption Value Market Share by Application (2017-2028)
    Figure 32. Global Coronary Drug-Coated Balloon Average Price by Application (2017-2028) & (US$/Unit)
    Figure 33. North America Coronary Drug-Coated Balloon Sales Quantity Market Share by Type (2017-2028)
    Figure 34. North America Coronary Drug-Coated Balloon Sales Quantity Market Share by Application (2017-2028)
    Figure 35. North America Coronary Drug-Coated Balloon Sales Quantity Market Share by Country (2017-2028)
    Figure 36. North America Coronary Drug-Coated Balloon Consumption Value Market Share by Country (2017-2028)
    Figure 37. United States Coronary Drug-Coated Balloon Consumption Value and Growth Rate (2017-2028) & (USD Million)
    Figure 38. Canada Coronary Drug-Coated Balloon Consumption Value and Growth Rate (2017-2028) & (USD Million)
    Figure 39. Mexico Coronary Drug-Coated Balloon Consumption Value and Growth Rate (2017-2028) & (USD Million)
    Figure 40. Europe Coronary Drug-Coated Balloon Sales Quantity Market Share by Type (2017-2028)
    Figure 41. Europe Coronary Drug-Coated Balloon Sales Quantity Market Share by Application (2017-2028)
    Figure 42. Europe Coronary Drug-Coated Balloon Sales Quantity Market Share by Country (2017-2028)
    Figure 43. Europe Coronary Drug-Coated Balloon Consumption Value Market Share by Country (2017-2028)
    Figure 44. Germany Coronary Drug-Coated Balloon Consumption Value and Growth Rate (2017-2028) & (USD Million)
    Figure 45. France Coronary Drug-Coated Balloon Consumption Value and Growth Rate (2017-2028) & (USD Million)
    Figure 46. United Kingdom Coronary Drug-Coated Balloon Consumption Value and Growth Rate (2017-2028) & (USD Million)
    Figure 47. Russia Coronary Drug-Coated Balloon Consumption Value and Growth Rate (2017-2028) & (USD Million)
    Figure 48. Italy Coronary Drug-Coated Balloon Consumption Value and Growth Rate (2017-2028) & (USD Million)
    Figure 49. Asia-Pacific Coronary Drug-Coated Balloon Sales Quantity Market Share by Region (2017-2028)
    Figure 50. Asia-Pacific Coronary Drug-Coated Balloon Sales Quantity Market Share by Application (2017-2028)
    Figure 51. Asia-Pacific Coronary Drug-Coated Balloon Sales Quantity Market Share by Region (2017-2028)
    Figure 52. Asia-Pacific Coronary Drug-Coated Balloon Consumption Value Market Share by Region (2017-2028)
    Figure 53. China Coronary Drug-Coated Balloon Consumption Value and Growth Rate (2017-2028) & (USD Million)
    Figure 54. Japan Coronary Drug-Coated Balloon Consumption Value and Growth Rate (2017-2028) & (USD Million)
    Figure 55. Korea Coronary Drug-Coated Balloon Consumption Value and Growth Rate (2017-2028) & (USD Million)
    Figure 56. India Coronary Drug-Coated Balloon Consumption Value and Growth Rate (2017-2028) & (USD Million)
    Figure 57. Southeast Asia Coronary Drug-Coated Balloon Consumption Value and Growth Rate (2017-2028) & (USD Million)
    Figure 58. Australia Coronary Drug-Coated Balloon Consumption Value and Growth Rate (2017-2028) & (USD Million)
    Figure 59. South America Coronary Drug-Coated Balloon Sales Quantity Market Share by Type (2017-2028)
    Figure 60. South America Coronary Drug-Coated Balloon Sales Quantity Market Share by Application (2017-2028)
    Figure 61. South America Coronary Drug-Coated Balloon Sales Quantity Market Share by Country (2017-2028)
    Figure 62. South America Coronary Drug-Coated Balloon Consumption Value Market Share by Country (2017-2028)
    Figure 63. Brazil Coronary Drug-Coated Balloon Consumption Value and Growth Rate (2017-2028) & (USD Million)
    Figure 64. Argentina Coronary Drug-Coated Balloon Consumption Value and Growth Rate (2017-2028) & (USD Million)
    Figure 65. Middle East & Africa Coronary Drug-Coated Balloon Sales Quantity Market Share by Type (2017-2028)
    Figure 66. Middle East & Africa Coronary Drug-Coated Balloon Sales Quantity Market Share by Application (2017-2028)
    Figure 67. Middle East & Africa Coronary Drug-Coated Balloon Sales Quantity Market Share by Region (2017-2028)
    Figure 68. Middle East & Africa Coronary Drug-Coated Balloon Consumption Value Market Share by Region (2017-2028)
    Figure 69. Turkey Coronary Drug-Coated Balloon Consumption Value and Growth Rate (2017-2028) & (USD Million)
    Figure 70. Egypt Coronary Drug-Coated Balloon Consumption Value and Growth Rate (2017-2028) & (USD Million)
    Figure 71. Saudi Arabia Coronary Drug-Coated Balloon Consumption Value and Growth Rate (2017-2028) & (USD Million)
    Figure 72. South Africa Coronary Drug-Coated Balloon Consumption Value and Growth Rate (2017-2028) & (USD Million)
    Figure 73. Coronary Drug-Coated Balloon Market Drivers
    Figure 74. Coronary Drug-Coated Balloon Market Restraints
    Figure 75. Coronary Drug-Coated Balloon Market Trends
    Figure 76. Porters Five Forces Analysis
    Figure 77. Manufacturing Cost Structure Analysis of Coronary Drug-Coated Balloon in 2021
    Figure 78. Manufacturing Process Analysis of Coronary Drug-Coated Balloon
    Figure 79. Coronary Drug-Coated Balloon Industrial Chain
    Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
    Figure 81. Direct Channel Pros & Cons
    Figure 82. Indirect Channel Pros & Cons
    Figure 83. Methodology
    Figure 84. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

B. Braun
Yinyi
Eurocor
Biotronic

Product Tags

coronary drug coated balloon

Coronary Drug-Coated Balloon

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>